TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 50,000 common shares of the Company at a deemed price of $0.10 per share, for a total value of $5,000, to an arm’s length service provider in settlement of services provided, as previously described in the Company’s press release dated February 4, 2015. The shares issued are subject to a four month hold period which will expire on June 18, 2015.
The Company also announced that it has granted an aggregate of 550,000 incentive stock options to members of its board of directors as compensation for their board participation. The options are exercisable at $0.135 per share for five years from the date of grant and will vest on June 30, 2015. The grant of options is subject to the provisions of the Company’s Stock Option Plan, the policies of the TSX Venture Exchange and applicable securities laws.
